When you take semaglutide, you likely notice that you feel satisfied with smaller portions and that your cravings for high-calorie foods begin to fade
Patients currently on or initiating a sulfonylurea may require lower sulfonylurea doses to reduce the risk of hypoglycemia [see Warnings and Precautions]
Mild injection site discomfort, redness, or bruising are expected and normal responses to any subcutaneous injection
Demand for products positioned around protein, functionality and fullness is climbing as consumers become more deliberate about what they eat and why they are eating it
GLP-1 receptors are distributed throughout the brain, with concentrations in the hypothalamus, brainstem, and areas involved in reward processing
5 These benefits might come from several factors: Weight loss itself improves mood and self-esteem Reduced inflammation (which is linked to depression) Direct effects on GLP-1 receptors in the brain, which are present in areas involved in mood regulation Improved physical function and mobility Healthier eating habits developed while on the medication Evidence suggesting caution is needed However, pharmacovigilance studies (which analyse reports of side effects submitted to drug safety databases) have identified signals for psychiatric adverse events with GLP-1 medications, including semaglutide
